Medical Devices
-
Medtronic recalls heart valve delivery catheter for risk of tip detaching
Certain delivery systems that are used to insert a pulmonary valve have an increased risk of distal tip detachment, the company said. The valve itself is not affected by the recall.
By Elise Reuter • July 14, 2026 -
HistoSonics wins Europe’s CE mark for histotripsy system
HistoSonics’ phased commercial rollout of the Edison system will initially target centers specializing in liver tumor treatment.
By Nick Paul Taylor • July 14, 2026 -
Explore the Trendline➔
Alamy
TrendlineDiagnostics is undergoing a transformation
The diagnostics industry is going through a phase of dealmaking, including Abbott’s $21 billion pickup of Exact Sciences, amid the growing presence of cancer screening tests.
By MedTech Dive staff -
Edwards will pay $10M to settle FTC charges of skirting antitrust review
The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to sidestep a Hart-Scott-Rodino review.
By Susan Kelly • July 13, 2026 -
Sponsored by Veeva MedTech
Expert insights to transform your evidence generation strategy
Modernize evidence generation with unified strategies and AI to accelerate time to market.
July 13, 2026 -
Illumina builds out C-suite with 2 new execs
The gene sequencing company this week named a new chief commercial officer and chief legal officer.
By Elise Reuter • July 10, 2026 -
Medicaroid wins Europe’s CE mark for Hinotori surgical robot
The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after expanding in the Asia-Pacific region.
By Susan Kelly • July 10, 2026 -
Stereotaxis closes Robocath takeover
With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic technologies for endovascular procedures.
By Susan Kelly • July 9, 2026 -
4 takeaways from MDUFA VI draft agreement
The draft agreement outlines the Food and Drug Administration’s goals for medical device reviews from 2028 to 2032.
By Elise Reuter • July 9, 2026 -
J&J wins FDA approval for dual-energy ablation catheter
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
By Nick Paul Taylor • July 9, 2026 -
Resmed to sell MatrixCare for $490M to private equity firm
Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.
By Susan Kelly • July 8, 2026 -
Top surgical robotics stories in the first half of 2026
The market for robotic surgery got more competitive this year, with Medtronic, Stryker, CMR Surgical and Distalmotion introducing new platforms. Check up on their progress and more in MedTech Dive’s roundup of robotics coverage.
By Susan Kelly • July 8, 2026 -
Insulet launches Omnipod 5 in Spain
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
By Nick Paul Taylor • July 7, 2026 -
Top 10 medtech deals in the first half of 2026
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
By Nick Paul Taylor • July 6, 2026 -
Medicare slashes 340B payments, broadens site-neutral policies in proposed 2027 payment rule
The rule, released Thursday, builds on Trump administration priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of care.
By Sydney Halleman • July 6, 2026 -
US blocks quick USMCA extension, putting annual review process into motion
The U.S., Mexico and Canada will continue negotiating about potential adjustments to the trilateral free trade agreement, which will remain in place until at least 2036.
By Phil Neuffer • July 2, 2026 -
Retrieved from Hologic on January 16, 2025
FDA updates Hologic BioZorb recall, citing 252 injuries
While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients who have had them implanted.
By Susan Kelly • July 1, 2026 -
FDA authorizes more devices so far in 2026, but it’s taking longer
Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.
By Elise Reuter • July 1, 2026 -
Roche takes on Illumina with new NGS system
When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.”
By Susan Kelly • June 30, 2026 -
DePuy Synthes names CFO ahead of J&J split
Christina Zamarro will take over the role in July after spending nearly 20 years at Goodyear Tire & Rubber Company, most recently serving as its CFO.
By Nick Paul Taylor • June 30, 2026 -
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic
Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.
By Susan Kelly • June 29, 2026 -
J&J starts pivotal trials of Shockwave IVL device in carotid arteries
J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.
By Nick Paul Taylor • June 29, 2026 -
Aidoc wins breakthrough nod for AI that reads chest X-rays
Aidoc is working on an artificial intelligence feature that would analyze chest X-rays and generate preliminary reports for more than 100 findings.
By Elise Reuter • June 26, 2026 -
Q&A
BD’s Bilal Muhsin talks AI in connected care
Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.
By Elise Reuter • Updated June 25, 2026 -
Tissium secures up to $68M to back rollout of nerve repair platform
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.
By Susan Kelly • June 25, 2026 -
MiniMed launches Abbott-made Instinct glucose sensor in Europe
Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.
By Nick Paul Taylor • June 24, 2026